The following sections 2.1-2.4 represent the approach to the process:

2.1 Format of ANDIAB2 when run in 2010

2.1.1 Recruitment of Centres

All Diabetes Centres members of NADC were invited to participate.

2.1.2 Data Items to be Collected

A sub-committee selected data items to be collected – based on experience in ANDIAB 2005. Items considered for collection in ANDIAB2 would include but not be restricted to:
  • Basic Demographic Data – Age, Sex, Diabetes Type, Duration and Therapy …;
  • Patient Self-care Practices
    • Carrying Identification? / Carrying Hypoglycaemia Rx [if relevant]? / DVA patient ? …;
  • Medication Use – Adherence
    • Possibly including assessment of the use of Alternative and Natural Therapies;
  • Quality Of Life assessment – [patient self administer – Centre record Score]
    • ? the SF 36
    • ? a simpler and validated tool – eg EuroQol EQ-5D, Centre for Health Economics, University of York, York - used in ANDIAB2 2005
    • ? Diabetes Distress Scale – validated 2 screening question, 17 item questionnaire with total score and 4 sub-scale score interpretations
  • Hypoglycaemia Awareness [if relevant];
  • Lipodystrophy Presence [if relevant];
  • Smoking;
  • Exercise – ?Type, Amount, Frequency;
  • Allied Health ‘Usage’ – ?number / frequency of visits,
    • including – educator, dietitian, podiatrist, psychologist, social worker, ?other;
  • Depression / Mood [utilizing the Brief Case Find for Depression [BCD] tool 1993 Monash Univ. Dept of Psychological Medicine. [This was first used in ANDIAB 2002 and also in ANDIAB2 2005].

2.1.3. Review of Project

Following the data collection phase of the Project, a questionnaire will be designed and administered seeking feedback on the data items and the process in general. A second questionnaire will be designed and administered seeking feedback on Diabetes Centre views of the reports received. The responses to these questionnaires will guide the Final Report and recommendations for future collections, which are proposed to be run second yearly in the alternate years to ANDIAB.

2.2 How the project can improve the care of patients with diabetes

The results of ANDIAB2 will be expected to provide an indication of the patient care practices and the process of care found amongst participating Centres throughout Australia. There will likely be
wide variation in these findings which may inform areas of practice or knowledge deficit amongst patients, or the need for service development or topic revision regarding the specific examples found. For instance – there may by poor carriage of hypoglycaemia therapy that needs to be reinforced or a significant degree of knowledge deficit identified that warrants increased attention by a particular Centre. Sharing this information in a Final Pooled Report should assist in identifying processes that could be adopted to improve education and clinical care which [once implemented] should result in improved outcomes for people attending those Centres.

2.3 How efficiency of ANDIAB2 will be assessed

This will be assessed in 2 ways:
  • the participation rate in ANDIAB2 itself;
  • the assessment of responses to the questionnaires.

2.4 Ethics Approval

This is a quality audit exercise utilising de-identified patient data from de-identified sites transmitted through a ‘trusted third party’ [the NADC Secretariat]. There is no disclosure of individual patient data. The usual ethics approval for the ANDIAB data collection will apply, which is, that each site determine how to address this within their individual setting.
Top of page